These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26558839)

  • 1. Validation of an Age-adjusted Prostate Cancer-Specific Comorbidity Index.
    Froehner M; Koch R; Hübler M; Wirth MP
    Eur Urol; 2016 May; 69(5):764-6. PubMed ID: 26558839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Froehner M; Koch R; Heberling U; Novotny V; Hübler M; Wirth MP
    Urol Oncol; 2017 Jan; 35(1):32.e17-32.e23. PubMed ID: 27519277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older.
    Froehner M; Koch R; Hübler M; Zastrow S; Wirth MP
    Eur Urol; 2017 May; 71(5):710-713. PubMed ID: 27793476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
    Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
    Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
    Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
    J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only <10% of Patients Selected for Radical Prostatectomy Reach the Competing Mortality Rate of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
    Froehner M; Koch R; Hübler M; Renner T; Borkowetz A; Zastrow S; Wirth MP
    Eur Urol Focus; 2019 May; 5(3):361-364. PubMed ID: 29426695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    BJU Int; 2012 Jul; 110(2):206-10. PubMed ID: 22044591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Age Adjusted Comorbidity Index to Predict Long-Term, Other Cause Mortality in Men with Prostate Cancer.
    Daskivich TJ; Kwan L; Dash A; Saigal C; Litwin MS
    J Urol; 2015 Jul; 194(1):73-8. PubMed ID: 25623745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
    Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy.
    Chen MS; Howard LE; Stock S; Dolgner A; Freedland SJ; Aronson W; Terris M; Klaassen Z; Kane C; Amling C; Cooperberg M; Daskivich TJ
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):715-721. PubMed ID: 35668181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy.
    Boehm K; Larcher A; Tian Z; Mandel P; Schiffmann J; Karakiewicz PI; Graefen M; Huland H; Tilki D
    J Urol; 2016 Jul; 196(1):82-8. PubMed ID: 26925872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
    Abdollah F; Schmitges J; Sun M; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
    Int J Urol; 2012 Sep; 19(9):836-44. PubMed ID: 22574746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of a novel easy-to-use mortality index in a radical prostatectomy cohort.
    Froehner M; Koch R; Hübler M; Litz R; Wirth MP
    Urology; 2014 Aug; 84(2):307-12. PubMed ID: 24962844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does increasing life expectancy affect competing mortality after radical prostatectomy?
    Froehner M; Koch R; Wirth MP; Adam M; Schlomm T; Huland H; Graefen M
    Urol Oncol; 2014 May; 32(4):413-8. PubMed ID: 24332647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy.
    Daskivich TJ; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Freedland SJ
    J Urol; 2020 Sep; 204(3):511-517. PubMed ID: 32243242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of comorbidity and age in radical prostatectomy].
    Wirth M; Fröhner M
    Urologe A; 2004 Aug; 43(8):935-41. PubMed ID: 15278203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
    Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
    J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which comorbidity classification best fits elderly candidates for radical prostatectomy?
    Froehner M; Hentschel C; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    Urol Oncol; 2013 May; 31(4):461-7. PubMed ID: 21498089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
    Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
    J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.